.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Maternal Vitamin B12 supplementation plays a critical role in the early neurodevelopmental outcomes of infants. Researchers recently conducted a randomized controlled trial in India and Nepal. They specifically focused on vegetarian women during their first trimester of pregnancy. Consequently, the study highlights a significant gap in current antenatal care guidelines. Many women in South Asia enter pregnancy with unrecognized B12 deficiency. Furthermore, standard care often focuses exclusively on iron and folic acid. This oversight may hinder optimal brain development during sensitive periods.
The trial compared two daily dosages of Vitamin B12 to assess efficacy. One group received 250 micrograms while the other received 50 micrograms. Interestingly, the higher dose led to a 30 percent reduction in biochemical deficiency. Moreover, infants in the high-dose group achieved superior mental development scores at 9-12 months. However, motor development remained similar between both groups. These findings suggest that higher intake levels are safe and effective. Additionally, these simple nutritional refinements could boost long-term human capital across the population. Consequently, clinicians should consider screening for B12 levels in vegetarian patients.
Q1: Why is B12 deficiency common in South Asian pregnant women?
Deficiency often arises because many populations consume limited animal-source foods. Predominantly vegetarian diets typically lack sufficient B12 levels to support both the mother and the developing child.
Q2: What was the specific dosage used for the high-intake group in the study?
The study utilized a daily dose of 250 micrograms of Vitamin B12 starting from the first trimester through six months post-delivery.
Q3: How does B12 deficiency affect infant growth?
Untreated deficiency during pregnancy is linked to delayed neurodevelopment. It also increases the risk of adverse pregnancy outcomes and reduced cognitive potential in early childhood.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study reveals that higher Vitamin B12 intake in pregnant vegetarian women significantly improves infant neurodevelopment and reduces maternal deficien...
5 months ago
A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Left ventricular thrombus is a severe complication of acute decompensated heart failure. This clinical review explores the pathophysiology, imaging challenges, and pharmacotherapeutic considerations of laminated thrombi, evaluating the evolving role of direct oral anticoagulants versus traditional warfarin.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
